PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic Steroids
Authors:
- W.V. PadulaWPW.V. Padula
- T. YilmazTYT. Yilmaz
- M. Cordero-ComaMCM. Cordero-Coma
- 1 November 2011
- journal article
- Published by Elsevier in Value in Health
- Vol. 14 (7) , A505-A506